1
|
Zhou B, Liao Y, Guo Y, Tarner IH, Liao C, Chen S, Kermany MH, Tu H, Zhong S, Chen P. Adoptive Cellular Gene Therapy for the Treatment of Experimental Autoimmune Polychondritis Ear Disease. ORL J Otorhinolaryngol Relat Spec 2017; 79:166-177. [PMID: 28463837 DOI: 10.1159/000452767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2015] [Accepted: 10/19/2016] [Indexed: 11/19/2022]
Abstract
In the past, the clinical therapy for autoimmune diseases, such as autoimmune polychondritis ear disease, was mostly limited to nonspecific immunosuppressive agents, which could lead to variable responses. Currently, gene therapy aims at achieving higher specificity and less adverse effects. This concept utilizes the adoptive transfer of autologous T cells that have been retrovirally transduced ex vivo to express and deliver immunoregulatory gene products to sites of autoimmune inflammation. In the animal model of collagen-induced autoimmune polychondritis ear disease (CIAPED), the adoptive transfer of IL-12p40-expressing collagen type II (CII)-specific CD4+ T-cell hybridomas resulted in a significantly lower disease incidence and severity compared with untreated or vector-only-treated animals. In vivo cell detection using bioluminescent labels showed that transferred CII-reactive T-cell hybridomas accumulated in the inflamed earlobes of the mice with CIAPED. In vitro analysis demonstrated that IL-12p40-transduced T cells did not affect antigen-specific T-cell activation or systemic anti-CII Ab responses. However, IL-12p40-transduced T cells suppressed IFN-γ and augmented IL-4 production, indicating their potential to act therapeutically by interrupting Th1-mediated inflammatory responses via augmenting Th2 responses. These results indicate that the local delivery of IL-12p40 by T cells could inhibit CIAPED by suppressing autoimmune responses at the site of inflammation.
Collapse
Affiliation(s)
- Bin Zhou
- Department of Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, PR China
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Siegemund S, Schütze N, Freudenberg MA, Lutz MB, Straubinger RK, Alber G. Production of IL-12, IL-23 and IL-27p28 by bone marrow-derived conventional dendritic cells rather than macrophages after LPS/TLR4-dependent induction by Salmonella Enteritidis. Immunobiology 2007; 212:739-50. [PMID: 18086375 DOI: 10.1016/j.imbio.2007.09.004] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2007] [Accepted: 09/28/2007] [Indexed: 10/22/2022]
Abstract
Induction of the interleukin-12 (IL-12) cytokine family comprising IL-12, IL-23, IL-27, and IL-12p40 by intracellular pathogens is required for orchestration of cell-mediated immune responses. Macrophages (MPhi) have been shown to be a source of IL-12 following TLR4-dependent activation by Salmonella (S.). In this study another antigen-presenting cell type, the conventional dendritic cell (cDC), was analyzed and its cytokine responses compared with those of MPhi. We generated bone marrow-derived conventional dendritic cells (BMDC) and macrophages (BMMPhi) by incubating murine bone marrow cells with supernatants containing granulocyte/macrophage colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF), respectively. Stimulation of BMDC and BMMPhi with S. enterica serovar Enteritidis (SE) or LPS resulted in the release of IL-12 and IL-23 by BMDC but not by BMMPhi. Furthermore, BMDC secreted approx. 20-fold more IL-12p40 and IL-27p28 than BMMPhi. However, BMDC and BMMPhi produced similar levels of IL-10. Using BMDC originating from wild-type (wt), TLR2(def) and TLR4(def) mice, we show that in BMDC the induction of IL-12, IL-23, and IL-27p28 by SE is dependent on TLR4, whereas low-level production of p40 is also mediated by pattern recognition receptors (PRR) other than TLR4. Interestingly, LPS- and SE-provoked responses of BMDC were remarkably similar indicating that LPS is the primary danger molecule of SE. Taken together, our results point to cDC rather than MPhi as the major producers of the IL-12 family members during in vitro infection with SE. The mechanisms of recognition of SE, however, appear to be the same for cDC and MPhi.
Collapse
Affiliation(s)
- Sabine Siegemund
- Institute of Immunology, College of Veterinary Medicine, An den Tierkliniken 11, 04103, Leipzig, Germany
| | | | | | | | | | | |
Collapse
|
6
|
Hasan M, Lopez-Herrera G, Blomberg KEM, Lindvall JM, Berglöf A, Smith CIE, Vargas L. Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice. Immunology 2007; 123:239-49. [PMID: 17725607 PMCID: PMC2433303 DOI: 10.1111/j.1365-2567.2007.02693.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Bruton's tyrosine kinase (Btk), a member of the Tec family of tyrosine kinases, plays an important role in the differentiation and activation of B cells. Mutations affecting Btk cause immunodeficiency in both humans and mice. In this study we set out to investigate the potential role of Btk in Toll-like receptor 9 (TLR9) activation and the production of pro-inflammatory cytokines such as interleukin (IL)-6, tumour necrosis factor (TNF)-alpha and IL-12p40. Our data show that Btk-deficient B cells respond more efficiently to CpG-DNA stimulation, producing significantly higher levels of pro-inflammatory cytokines but lower levels of the inhibitory cytokine IL-10. The quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis presented in this work shows that mRNA production of one of the important new members of the IL-12 family, IL-27, was significantly increased in Btk-deficient B cells after CpG-DNA stimulation. In this study, we demonstrate significant differences in CpG responsiveness between transitional 1 (T1) and T2 B cells for survival and maturation. Furthermore, TLR9 expression, measured both as protein and as mRNA, was increased in Btk-defective cells, especially after TLR9 stimulation. Collectively, these data provide evidence in support of the theory that Btk regulates both TLR9 activation and expression in mouse splenic B cells.
Collapse
Affiliation(s)
- Maroof Hasan
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University HospitalStockholm, Sweden
| | - Gabriela Lopez-Herrera
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University HospitalStockholm, Sweden
- Molecular Biomedicine Department at Center for Research and Advanced Studies, National Institute of TechnologyMexico City, Mexico
| | - K Emelie M Blomberg
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University HospitalStockholm, Sweden
| | | | - Anna Berglöf
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University HospitalStockholm, Sweden
| | - C I Edvard Smith
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University HospitalStockholm, Sweden
| | - Leonardo Vargas
- Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Karolinska University HospitalStockholm, Sweden
| |
Collapse
|
8
|
Stratis A, Pasparakis M, Rupec RA, Markur D, Hartmann K, Scharffetter-Kochanek K, Peters T, van Rooijen N, Krieg T, Haase I. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 2006; 116:2094-104. [PMID: 16886058 PMCID: PMC1525004 DOI: 10.1172/jci27179] [Citation(s) in RCA: 159] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2005] [Accepted: 06/01/2006] [Indexed: 01/20/2023] Open
Abstract
Psoriasis is a common skin disease, the pathogenesis of which has not yet been resolved. In mice, epidermis-specific deletion of inhibitor of NF-kappaB (IkappaB) kinase 2 (IKK2) results in a skin phenotype that mimics human psoriasis in several aspects. Like psoriasis, this skin disease shows pronounced improvement when mice are treated with a TNF-neutralizing agent. We have found previously that this phenotype does not depend on the presence of alphabeta T lymphocytes. In order to evaluate contributions of other immune cell populations to the skin disease, we selectively eliminated macrophages and granulocytes from the skin of mice with epidermis-specific deletion of IKK2 (K14-Cre-IKK2fl/fl mice). Elimination of skin macrophages by subcutaneous injection of clodronate liposomes was accompanied by inhibition of granulocyte migration into the skin and resulted in a dramatic attenuation of psoriasis-like skin changes. The hyperproliferative, inflammatory skin disease in K14-Cre-IKK2fl/fl mice was a direct consequence of the presence of macrophages in the skin, as targeted deletion of CD18, which prevented accumulation of granulocytes but not macrophages, did not lead to major changes in the phenotype. Targeted deletion of the receptor for IFN-gamma revealed that the pathogenesis of the skin disease does not depend on classical IFN-gamma-mediated macrophage activation. Our results demonstrate that in mice epidermal keratinocytes can initiate a hyperproliferative, inflammatory, IFN-gamma-independent, psoriasis-like skin disease whose development requires essential contributions from skin macrophages but not from granulocytes or alphabeta T lymphocytes.
Collapse
Affiliation(s)
- Athanasios Stratis
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Manolis Pasparakis
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Rudolf A. Rupec
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Doreen Markur
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Karin Hartmann
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Karin Scharffetter-Kochanek
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Thorsten Peters
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Nico van Rooijen
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Thomas Krieg
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| | - Ingo Haase
- Department of Dermatology and Center for Molecular Medicine, University of Cologne (CMMC), Cologne, Germany.
European Molecular Biology Laboratory, Mouse Biology Unit, Monterotondo, Italy.
Institute for Genetics, University of Cologne, Cologne, Germany.
Department of Dermatology, University of Munich, Munich, Germany.
Department of Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany.
Department of Cell Biology, Free University, Amsterdam, The Netherlands
| |
Collapse
|